Surgery Partners, Inc.

NasdaqGS:SGRY Rapporto sulle azioni

Cap. di mercato: US$4.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Surgery Partners Gestione

Gestione criteri di controllo 3/4

Surgery Partners' Il CEO è J. Evans, nominato in Jan2020, e ha un mandato di 4.58 anni. la retribuzione annua totale è $ 6.46M, composta da 16.3% di stipendio e 83.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.36% delle azioni della società, per un valore di $ 13.34M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.1 anni e 6.3 anni.

Informazioni chiave

J. Evans

Amministratore delegato

US$6.5m

Compenso totale

Percentuale dello stipendio del CEO16.3%
Mandato del CEO4.6yrs
Proprietà del CEO0.4%
Durata media del management3.1yrs
Durata media del Consiglio di amministrazione6.3yrs

Aggiornamenti recenti sulla gestione

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Recent updates

Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Jul 25
Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Jul 13
Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Jun 21
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Mar 27
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Dec 06
Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di J. Evans rispetto agli utili di Surgery Partners?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$34m

Mar 31 2024n/an/a

US$600k

Dec 31 2023US$6mUS$1m

-US$12m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$92m

Dec 31 2022US$6mUS$1m

-US$55m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$38m

Dec 31 2021US$4mUS$1m

-US$81m

Sep 30 2021n/an/a

-US$86m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$150m

Dec 31 2020US$4mUS$916k

-US$156m

Sep 30 2020n/an/a

-US$179m

Jun 30 2020n/an/a

-US$132m

Mar 31 2020n/an/a

-US$119m

Dec 31 2019US$5mUS$435k

-US$110m

Compensazione vs Mercato: La retribuzione totale di J. ($USD 6.46M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 6.76M ).

Compensazione vs guadagni: La retribuzione di J. è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

J. Evans (47 yo)

4.6yrs

Mandato

US$6,457,600

Compensazione

Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Wayne DeVeydt
Executive Chairman6.6yrsUS$250.00k0.080%
$ 3.4m
J. Evans
CEO & Director4.6yrsUS$6.46m0.36%
$ 15.5m
David Doherty
Executive VP & CFO2.5yrsUS$3.52m0.076%
$ 3.2m
Jennifer Baldock
Executive VP and Chief Administrative & Development Officer4.5yrsUS$3.09m0.15%
$ 6.2m
Bradley Owens
President of National Group4.7yrsUS$1.61m0.057%
$ 2.4m
Marissa Brittenham
Executive VP & Chief Strategy Officer2.6yrsUS$1.68m0.031%
$ 1.3m
Neil Zieselman
Senior Vice President of Corporate Finance & Controller2.3yrsNessun datoNessun dato
Varun Gadhok
Senior VP & Chief Information Officer3.1yrsNessun datoNessun dato
Roxanne Womack
Senior VP & Chief Compliance Officer5.8yrsNessun datoNessun dato
Spencer Clark
General Counsel & Senior VPless than a yearNessun datoNessun dato
Danielle Burkhalter
Executive VP & Chief Human Resources Officer1.5yrsNessun dato0.024%
$ 1.0m
Anthony Taparo
Chief Growth Officer5yrsUS$1.30m0.081%
$ 3.4m

3.1yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di SGRY è considerato esperto (durata media dell'incarico 3.1 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Wayne DeVeydt
Executive Chairman6.6yrsUS$250.00k0.080%
$ 3.4m
J. Evans
CEO & Director4.6yrsUS$6.46m0.36%
$ 15.5m
Clifford Adlerz
Director6.8yrsUS$260.00k0.040%
$ 1.7m
Blair Hendrix
Director3.3yrsNessun datoNessun dato
William Turner
Independent Director8.7yrsUS$285.00k0.054%
$ 2.3m
Patricia Maryland
Independent Director3.5yrsUS$260.00k0.014%
$ 597.0k
Teresa DeLuca
Independent Director7.9yrsUS$280.00k0.046%
$ 2.0m
John Deane
Independent Director5.3yrsUS$260.00k0.022%
$ 922.7k
T. O'Reilly
Director7yrsNessun datoNessun dato
Andrew Kaplan
Director6yrsNessun datoNessun dato

6.3yrs

Durata media

58yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SGRY sono considerati esperti (durata media dell'incarico 6.3 anni).